ENVALITH
株式会社セルシード logo

CellSeed Inc.

7776Growth MarketPrecision Instruments

株式会社セルシード logo
CellSeed Inc.7776
Reference Indicators

Market Cap

85¥100M

P/E (Forecast)

P/B

6.2x

Dividend Yield (Forecast)

0.00%

ROE

-87.9%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
16112619019383
Cost of Sales
7765828340
Gross Profit
846110711042
SG&A Expenses
9488048049561,088
Operating Income
-864-743-697-846-1,046
Non-operating Income
11033
Non-operating Expenses
23121358
Ordinary Income
-887-754-710-847-1,051
Extraordinary Income
121682
Extraordinary Losses
2561511852
Pre-tax Income
-910-758-845-857-1,101
Income Taxes
30022
Net Income
-914-759-846-859-1,104
EBITDA
-862-735-689
Gross Margin
52.0%48.3%56.4%57.0%51.1%
Operating Margin
-534.8%-587.9%-367.0%-437.9%-1250.2%
ROA
-65.7%-49.2%-34.3%-35.3%-66.7%
ROE
-91.2%-65.8%-39.5%-40.0%-87.9%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
再生医療支援事業81-104-128.4%
細胞シート再生医療事業1-722-72200.0%